BR112014026582A2 - método para identificar agentes capazes de induzir a sensibilização respiratória e matriz e kits analíticos para uso no método - Google Patents
método para identificar agentes capazes de induzir a sensibilização respiratória e matriz e kits analíticos para uso no métodoInfo
- Publication number
- BR112014026582A2 BR112014026582A2 BR112014026582A BR112014026582A BR112014026582A2 BR 112014026582 A2 BR112014026582 A2 BR 112014026582A2 BR 112014026582 A BR112014026582 A BR 112014026582A BR 112014026582 A BR112014026582 A BR 112014026582A BR 112014026582 A2 BR112014026582 A2 BR 112014026582A2
- Authority
- BR
- Brazil
- Prior art keywords
- agents capable
- identifying agents
- sensitization
- inducing respiratory
- kits
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 7
- 206010070834 Sensitisation Diseases 0.000 title abstract 3
- 230000001939 inductive effect Effects 0.000 title abstract 3
- 230000000241 respiratory effect Effects 0.000 title abstract 3
- 230000008313 sensitization Effects 0.000 title abstract 3
- 239000011159 matrix material Substances 0.000 title abstract 2
- 238000009007 Diagnostic Kit Methods 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 238000000338 in vitro Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5023—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects on expression patterns
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/24—Immunology or allergic disorders
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201207297A GB201207297D0 (en) | 2012-04-26 | 2012-04-26 | Analytical methods and arrays for use in the same |
| PCT/IB2013/053321 WO2013160882A1 (en) | 2012-04-26 | 2013-04-26 | Method for identifying agents capable of inducing respiratory sensitization and array and analytical kits for use in the method. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014026582A2 true BR112014026582A2 (pt) | 2017-06-27 |
Family
ID=46261886
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014026582A BR112014026582A2 (pt) | 2012-04-26 | 2013-04-26 | método para identificar agentes capazes de induzir a sensibilização respiratória e matriz e kits analíticos para uso no método |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US20150111771A1 (https=) |
| EP (1) | EP2841599A4 (https=) |
| KR (1) | KR20150016523A (https=) |
| CN (1) | CN104685067A (https=) |
| BR (1) | BR112014026582A2 (https=) |
| CA (1) | CA2871350A1 (https=) |
| GB (1) | GB201207297D0 (https=) |
| HK (1) | HK1211059A1 (https=) |
| IN (1) | IN2014MN02397A (https=) |
| WO (1) | WO2013160882A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201421207D0 (en) * | 2014-11-28 | 2015-01-14 | Senzagen Ab | Analytical methods and arrays for use in the same |
| GB201700138D0 (en) | 2017-01-05 | 2017-02-22 | Senzagen Ab | Analytical methods and arrays for use in the same |
| JP7023857B2 (ja) * | 2016-03-23 | 2022-02-22 | センソシェン アクティエ ボラーグ | 解析方法およびそれに用いるアレイ |
| TWI793151B (zh) | 2017-08-23 | 2023-02-21 | 瑞士商諾華公司 | 3-(1-氧異吲哚啉-2-基)之氫吡啶-2,6-二酮衍生物及其用途 |
| GB201715445D0 (en) | 2017-09-25 | 2017-11-08 | Senzagen Ab | Novel cell line and uses thereof |
| CN109828113A (zh) * | 2017-11-23 | 2019-05-31 | 复旦大学附属肿瘤医院 | PAPSS1在制备筛选α干扰素治疗肝癌敏感人群标志物的制剂中的用途 |
| CN108304912B (zh) * | 2017-12-29 | 2020-12-29 | 北京理工大学 | 一种运用抑制信号实现脉冲神经网络监督学习的系统和方法 |
| AR116109A1 (es) | 2018-07-10 | 2021-03-31 | Novartis Ag | Derivados de 3-(5-amino-1-oxoisoindolin-2-il)piperidina-2,6-diona y usos de los mismos |
| DK3820573T3 (da) | 2018-07-10 | 2023-10-23 | Novartis Ag | 3-(5-hydroxy-1-oxoisoindolin-2-yl)piperidin-2,6-dion-derivativer og anvendelse deraf ved behandling af ikaros family zinc finger 2 (ikzf2)-afhængige sygdomme |
| WO2020141204A2 (en) | 2019-01-03 | 2020-07-09 | Senzagen Ab | Analytical methods and arrays for use in the same |
| EP4130739A4 (en) * | 2020-03-25 | 2023-06-14 | FUJIFILM Corporation | METHOD FOR MEASUREMENT OF RESPIRATORY SENSITIZATION AND REAGENT FOR MEASUREMENT OF RESPIRATORY SENSITIZATION |
| CN111596067B (zh) * | 2020-06-03 | 2021-06-22 | 四川大学华西第二医院 | Zc3h8在pop早期预警、诊断、预后评估中的应用和产品 |
| CA3222964A1 (en) * | 2021-07-02 | 2023-01-05 | Regeneron Pharmaceuticals, Inc. | Methods of treating asthma with solute carrier family 27 member 3 (slc27a3) inhibitors |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4486530A (en) | 1980-08-04 | 1984-12-04 | Hybritech Incorporated | Immunometric assays using monoclonal antibodies |
| US4376110A (en) | 1980-08-04 | 1983-03-08 | Hybritech, Incorporated | Immunometric assays using monoclonal antibodies |
| US5856090A (en) | 1994-09-09 | 1999-01-05 | The Scripps Research Institute | DNA-methylase linking reaction |
| GB9703369D0 (en) | 1997-02-18 | 1997-04-09 | Lindqvist Bjorn H | Process |
| CA2608167C (en) * | 2005-05-12 | 2012-05-01 | Corporation Nuvolt Inc. | Current sensor |
| EP1905843A1 (en) * | 2006-09-29 | 2008-04-02 | Vlaamse Instelling voor Technologisch Onderzoek | Method for determining the allergic potential of a compound |
| US20090029868A1 (en) * | 2006-10-31 | 2009-01-29 | Applera Corporation | Expression signature in peripheral blood for detection of aortic aneurysm |
| GB201018014D0 (en) | 2010-10-26 | 2010-12-08 | Senzagen Ab | Analytical methods and arrays for use in the same |
-
2012
- 2012-04-26 GB GB201207297A patent/GB201207297D0/en not_active Ceased
-
2013
- 2013-04-26 CA CA2871350A patent/CA2871350A1/en not_active Abandoned
- 2013-04-26 US US14/396,422 patent/US20150111771A1/en not_active Abandoned
- 2013-04-26 WO PCT/IB2013/053321 patent/WO2013160882A1/en not_active Ceased
- 2013-04-26 BR BR112014026582A patent/BR112014026582A2/pt not_active IP Right Cessation
- 2013-04-26 EP EP13781556.9A patent/EP2841599A4/en not_active Withdrawn
- 2013-04-26 IN IN2397MUN2014 patent/IN2014MN02397A/en unknown
- 2013-04-26 CN CN201380031747.7A patent/CN104685067A/zh active Pending
- 2013-04-26 HK HK15111843.9A patent/HK1211059A1/xx unknown
- 2013-04-26 KR KR20147033326A patent/KR20150016523A/ko not_active Withdrawn
-
2017
- 2017-06-16 US US15/624,955 patent/US20170283874A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP2841599A1 (en) | 2015-03-04 |
| US20170283874A1 (en) | 2017-10-05 |
| IN2014MN02397A (https=) | 2015-08-21 |
| GB201207297D0 (en) | 2012-06-06 |
| WO2013160882A1 (en) | 2013-10-31 |
| KR20150016523A (ko) | 2015-02-12 |
| CA2871350A1 (en) | 2013-10-31 |
| HK1211059A1 (en) | 2016-05-13 |
| US20150111771A1 (en) | 2015-04-23 |
| CN104685067A (zh) | 2015-06-03 |
| EP2841599A4 (en) | 2015-12-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014026582A2 (pt) | método para identificar agentes capazes de induzir a sensibilização respiratória e matriz e kits analíticos para uso no método | |
| BR112015022934A2 (pt) | esteroides neuroativos, composições, e uso do mesmo | |
| BR112015023425A2 (pt) | método e composição para coloração e processamento de uma amostra de urina | |
| CA2815892C (en) | Analytical methods and arrays for use in the same | |
| BR112015020098A2 (pt) | método e composição para coloração e processamento de amostras | |
| BR112017011026A2 (pt) | métodos analíticos e arranjos para uso nos mesmos | |
| BR112016004320A2 (pt) | biossensor, sistema, kit, métodos de determinação ou de identificação e de quantificação de uma concentração de amônia ou íon amônio, de diagnóstico de uma doença metabólica em um sujeito, de determinação da resposta do paciente a uma terapia, de fabricação de um biossensor, de um sistema ou de qualquer tira de teste e de detecção da presença, ausência, ou quantidade de aminoácidos em uma amostra, e, tira de teste | |
| BR112016012968A2 (pt) | Métodos e composições para o tratamento de condições associadas com o envelhecimento | |
| MX389730B (es) | Extinguidor que contiene nanomaterial conjugado con polimero soluble en agua y su uso. | |
| BR112014007717A2 (pt) | composições e métodos para teste de toxicidade | |
| BR112014025384A8 (pt) | método e sistema para executar ensaio automatizado e métodos para executar teste reflexivo em vários exemplares | |
| BR112012031071A2 (pt) | 8-proteínas de ligação à il-1 | |
| BR112016008970A2 (pt) | Método de ativação ex vivo e para avaliar ativação plasmática em um indivíduo, ensaio ex vivo para determinar atividade de calicreína plasmática em uma amostra | |
| BR112015026601A2 (pt) | método para um ensaio de triagem de fármaco à base de células e o uso do mesmo | |
| BR112016024072A2 (pt) | métodos, kits e aparelho para ampliar uma população de células | |
| BR112014020083A8 (pt) | Dispositivos indicadores biológicos de esterilização e métodos de uso | |
| BR112014018331A8 (pt) | Biomarcadores e terapias combinadas usando vírus oncolítico e imunomodulação | |
| AR090884A1 (es) | Moleculas de anticuerpo anti-gcc y uso de las mismas para probar la susceptibilidad a la terapia dirigida a gcc | |
| BR112014018728A8 (pt) | Compostos de purinonas como inibidores de quinase | |
| BR122018069446B8 (pt) | método in vitro para detectar a presença de um célula de câncer em um indivíduo | |
| BR112015018434A2 (pt) | método, e, conjunto para medir uma vitamina d | |
| BR112016008956A2 (pt) | Detecção de atividade de clivagem de uma enzima | |
| BR112018069279A2 (pt) | métodos analíticos e matrizes para uso no mesmo | |
| BR112015023117A2 (pt) | composições de agente ativo retinóide particulado fino seco e formulações tópicas incluindo as mesmas | |
| BR112015025255A2 (pt) | métodos e arranjos para uso no mesmo |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25G | Requested change of headquarter approved |
Owner name: SENZAGEN AB (SE) |
|
| B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 6A ANUIDADE. |
|
| B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2515 DE 19-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |